During the compensatory phase of diabetes (i.e., hyperinsulinemia), IRMs secrete VEGF-A to promote angiogenesis, supporting islet hypertrophy and increased vascular density, thereby maintaining β-cell insulin secretion. This evidence concerns the gene INS and diabetes mellitus.